- Home
- UGRO vs TXMD Comparison
UGRO vs TXMD Comparison
Compare UGRO & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- TXMD
- Stock Information
- Founded
- UGRO 2014
- TXMD 2008
- Country
- UGRO United States
- TXMD United States
- Employees
- UGRO N/A
- TXMD N/A
- Industry
- UGRO Industrial Specialties
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- TXMD Health Care
- Exchange
- UGRO Nasdaq
- TXMD Nasdaq
- Market Cap
- UGRO 18.0M
- TXMD 17.9M
- IPO Year
- UGRO N/A
- TXMD N/A
- Fundamental
- Price
- UGRO $1.43
- TXMD $1.41
- Analyst Decision
- UGRO Strong Buy
- TXMD
- Analyst Count
- UGRO 2
- TXMD 0
- Target Price
- UGRO $5.63
- TXMD N/A
- AVG Volume (30 Days)
- UGRO 41.9K
- TXMD 17.4K
- Earning Date
- UGRO 11-22-2024
- TXMD 11-12-2024
- Dividend Yield
- UGRO N/A
- TXMD N/A
- EPS Growth
- UGRO N/A
- TXMD N/A
- EPS
- UGRO N/A
- TXMD N/A
- Revenue
- UGRO $70,320,066.00
- TXMD $1,596,000.00
- Revenue This Year
- UGRO $14.76
- TXMD $605.07
- Revenue Next Year
- UGRO $21.29
- TXMD $1.11
- P/E Ratio
- UGRO N/A
- TXMD N/A
- Revenue Growth
- UGRO 12.08
- TXMD N/A
- 52 Week Low
- UGRO $1.02
- TXMD $1.38
- 52 Week High
- UGRO $2.84
- TXMD $3.07
- Technical
- Relative Strength Index (RSI)
- UGRO 43.12
- TXMD 19.09
- Support Level
- UGRO $1.42
- TXMD $1.47
- Resistance Level
- UGRO $1.69
- TXMD $1.58
- Average True Range (ATR)
- UGRO 0.15
- TXMD 0.06
- MACD
- UGRO -0.04
- TXMD -0.01
- Stochastic Oscillator
- UGRO 3.92
- TXMD 13.23
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.